COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,886 Articles (22,568 medRxiv, 8,318 bioRxiv)

Most recent first Previous |  Page 694: Articles 6931-6940  | Next

Pre-Omicron vaccine breakthrough infection induces superior cross-neutralization against SARS-CoV-2 Omicron BA.1 than primo infection
Santos da Silva, E., Kohnen, M., Gilson, G., Staub, T., Arendt, V., Servais, J.-Y., Charpentier, E., Domingues, O., Snoeck, C. J., Ollert, M., Seguin-Devaux, C., Perez-Bercoff, D.
10.1101/2022.06.21.22276659 — Posted: 2022-06-23
Heterogeneity and district-level factors associated with COVID-19 mortality during three epidemic waves in Indonesia: a nationwide ecological study
Surendra, H., Paramita, D., Arista, N. N., Putri, A. I., Siregar, A. A., Puspaningrum, E., Rosylin, L., Gardera, D., Girianna, M., Elyazar, I. R.
10.1101/2022.06.20.22276672 — Posted: 2022-06-23
COVID-19 vaccine breakthrough infections among fully vaccinated Health Care Workers in Lagos, Nigeria
Oladele, D. A., Salako, A., Ayorinde, J., Onwuamah, C., Usman, O., Abubakar, R., Liboro, G., Odubela, O., Mogaji, S., Ige, F., Ohihoin, G., Ezechi, O., Audu, R., Adegbola, R. A., Dada, A., Salako, T.
10.1101/2022.06.22.22276765 — Posted: 2022-06-22
Acceleration of regional, racial and gender disparities in drug overdoses across the United States driven by COVID-19 and fentanyl use
Böttcher, L., D'Orsogna, M. R., Chou, T.
10.1101/2022.06.22.22276766 — Posted: 2022-06-22
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients
Goncalves, B. P., ISARIC Clinical Characterisation Group, , Hall, M. D., Jassat, W., Balan, V., Murthy, S., Kartsonaki, C., Semple, C., Rojek, A., Baruch, J., Reyes, L. F., Dasgupta, A., Dunning, J., Citarella, B. W., Pritchard, M., Martin-Quiros, A., Sili, U., Baillie, J. K., Aryal, D., Arabi, Y., Rashan, A., Angheben, A., Caoili, J., Carrier, F. M., Harrison, E. M., Gomez-Junyent, J., Figueiredo-Mello, C., Douglas, J. J., Mat Nor, M. B., Chow, Y. P., Wong, X. C., Bertagnolio, S., Thwin, S. S., Streinu-Cercel, A., Salazar, L., Rishu, A., Rangappa, R., Ong, D. S. Y., Hashmi, M., Carson, G., Diaz, J., Fowler, R., U G Kraemer, M., Wils, E.-J., Horby, P. W., Merson, L., Olliaro, P. L.
10.1101/2022.06.22.22276764 — Posted: 2022-06-22
Natural course of post COVID-19 condition and implications for trial design and outcome selection: A population-based longitudinal cohort study
Ballouz, T., Menges, D., Anagnostopoulos, A., Domenghino, A., Aschmann, H. E., Frei, A., Fehr, J. S., Puhan, M. A.
10.1101/2022.06.22.22276746 — Posted: 2022-06-22
U.S. state-level COVID-19 transmission insights from a mechanistic mobility-incidence model
Thommes, E. W., Mohammadi, Z., Flynn-Primrose, D., Smook, S., Gomez, G., Chaves, S. S., Coudeville, L., van Aalst, R., Mahe, C., Cojocaru, M. G.
10.1101/2022.06.21.22276712 — Posted: 2022-06-22
Within-host evolutionary dynamics and tissue compartmentalization during acute SARS-CoV-2 infection
Farjo, M., Koelle, K., Martin, M. A., Gibson, L. L., Walden, K. K., Rendon, G., Fields, C. J., Alnaji, F., Gallagher, N., Luo, C. H., Mostafa, H. H., Manabe, Y. C., Pekosz, A., Smith, R. L., McManus, D. D., Brooke, C. B.
10.1101/2022.06.21.497047 — Posted: 2022-06-22
Mutational insights among the structural proteins of SARS-CoV-2: frequencies and evolutionary trends in American countries
Abavisani, M., Rahimian, K., Khayami, R., Mollapour Sisakht, M., Mahmanzar, M., Meshkat, Z.
10.1101/2022.06.22.497134 — Posted: 2022-06-22
Fc-modified SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models.
Takeshita, M., Fukuyama, H., Kamada, K., Matsumoto, T., Makino-Okamura, C., Uchikubo-Kamo, T., Tomabechi, Y., Hanada, K., Moriyama, S., Takahashi, Y., Ishigaki, H., Nakayama, M., Nguyen, C. T., Kitagawa, Y., Itoh, Y., Imai, M., Maemura, T., Furusawa, Y., Ueki, H., Iwatsuki-Horimoto, K., Ito, M., Yamayoshi, S., Kawaoka, Y., Shirouzu, M., Ishii, M., Saya, H., Kondo, Y., Kaneko, Y., Suzuki, K., Fukunaga, K., Takeuchi, T.
10.1101/2022.06.21.496751 — Posted: 2022-06-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).